Literature DB >> 23737015

Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.

Yibing Mu1, Yongheng Chen, Guiying Zhang, Xianquan Zhan, Yuanyuan Li, Ting Liu, Guoqing Li, Maoyu Li, Zhefeng Xiao, Xiaoxiang Gong, Zhuchu Chen.   

Abstract

Tumor microenvironment plays very important roles in the carcinogenesis. A variety of stromal cells in the microenvironment have been modified to support the unique needs of the malignant state. This study was to discover stromal differentially expressed proteins (DEPs) that were involved in colon carcinoma carcinogenesis. Laser capture microdissection (LCM) was captured and isolated the stromal cells from colon adenocarcinoma (CAC) and non-neoplastic colon mucosa (NNCM) tissues, respectively. Seventy DEPs were identified between the pooled LCM-enriched CAC and NNCM stroma samples by iTRAQ-based quantitative proteomics. Gene Ontology (GO) relationship analysis revealed that DEPs were hierarchically grouped into 10 clusters, and were involved in multiple biological functions that were altered during carcinogenesis, including extracellular matrix organization, cytoskeleton, transport, metabolism, inflammatory response, protein polymerization, and cell motility. Pathway network analysis revealed 6 networks and 56 network eligible proteins with Ingenuity pathway analysis. Four significant networks functioned in digestive system development and its function, inflammatory disease, and developmental disorder. Eight DEPs (DCN, FN1, PKM2, HSP90B1, S100A9, MYH9, TUBB, and YWHAZ) were validated by Western blotting, and four DEPs (DCN, FN1, PKM2, and HSP90B1) were validated by immunohistochemical analysis. It is the first report of stromal DEPs between CAC and NNCM tissues. It will be helpful to recognize the roles of stromas in the colon carcinoma microenvironment, and improve the understanding of carcinogenesis in colon carcinoma. The present data suggest that DCN, FN1, PKM2, HSP90B1, S100A9, MYH9, TUBB, and YWHAZ might be the potential targets for colon cancer prevention and therapy.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23737015     DOI: 10.1002/elps.201200596

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  23 in total

1.  Global analysis reveals the complexity of the human glomerular extracellular matrix.

Authors:  Rachel Lennon; Adam Byron; Jonathan D Humphries; Michael J Randles; Alex Carisey; Stephanie Murphy; David Knight; Paul E Brenchley; Roy Zent; Martin J Humphries
Journal:  J Am Soc Nephrol       Date:  2014-01-16       Impact factor: 10.121

2.  Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer.

Authors:  Fang Peng; Ying Huang; Mao-Yu Li; Guo-Qing Li; Hui-Chao Huang; Rui Guan; Zhu-Chu Chen; Song-Ping Liang; Yong-Heng Chen
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

3.  Comparative two-dimensional polyacrylamide gel electrophoresis of the salivary proteome of children with autism spectrum disorder.

Authors:  Armand G Ngounou Wetie; Kelly L Wormwood; Laci Charette; Jeanne P Ryan; Alisa G Woods; Costel C Darie
Journal:  J Cell Mol Med       Date:  2015-08-20       Impact factor: 5.310

4.  Chemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stress.

Authors:  Jeffrey M Dick
Journal:  PeerJ       Date:  2017-06-06       Impact factor: 2.984

5.  OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages.

Authors:  Marie-Alice Meuwis; Edouard Louis; Florence Quesada-Calvo; Charlotte Massot; Virginie Bertrand; Rémi Longuespée; Noëlla Blétard; Joan Somja; Gabriel Mazzucchelli; Nicolas Smargiasso; Dominique Baiwir; Marie-Claire De Pauw-Gillet; Philippe Delvenne; Michel Malaise; Carla Coimbra Marques; Marc Polus; Edwin De Pauw
Journal:  Clin Proteomics       Date:  2017-03-24       Impact factor: 3.988

6.  Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.

Authors:  Guoqing Li; Maoyu Li; Xujun Liang; Zhefeng Xiao; Pengfei Zhang; Meiying Shao; Fang Peng; Yongheng Chen; Yuanyuan Li; Zhuchu Chen
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

7.  Proteomic alterations in early stage cervical cancer.

Authors:  Coşkun Güzel; Natalia I Govorukhina; G Bea A Wisman; Christoph Stingl; Lennard J M Dekker; Harry G Klip; Harry Hollema; Victor Guryev; Peter L Horvatovich; Ate G J van der Zee; Rainer Bischoff; Theo M Luider
Journal:  Oncotarget       Date:  2018-04-06

8.  Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.

Authors:  Maoyu Li; Fang Peng; Guoqing Li; Yang Fu; Ying Huang; Zhuchu Chen; Yongheng Chen
Journal:  Oncotarget       Date:  2016-06-14

9.  Proteomic indicators of oxidation and hydration state in colorectal cancer.

Authors:  Jeffrey M Dick
Journal:  PeerJ       Date:  2016-07-20       Impact factor: 2.984

10.  Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells.

Authors:  David T Ting; Ben S Wittner; Matteo Ligorio; Nicole Vincent Jordan; Ajay M Shah; David T Miyamoto; Nicola Aceto; Francesca Bersani; Brian W Brannigan; Kristina Xega; Jordan C Ciciliano; Huili Zhu; Olivia C MacKenzie; Julie Trautwein; Kshitij S Arora; Mohammad Shahid; Haley L Ellis; Na Qu; Nabeel Bardeesy; Miguel N Rivera; Vikram Deshpande; Cristina R Ferrone; Ravi Kapur; Sridhar Ramaswamy; Toshi Shioda; Mehmet Toner; Shyamala Maheswaran; Daniel A Haber
Journal:  Cell Rep       Date:  2014-09-18       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.